O Fórum Sepse está chegando! Faltam:
Professor Szabo is an internationally recognized expert in the fields of oxidative and nitrosative stress, gaseous transmitters, cell death, cell dysfunction, cardiovascular, and inflammatory mechanisms. In the mid 90's he has pioneered the concept that identified the pathogenetic role of the nuclear enzyme PARP in promoting cell necrosis, and its roles in cardiovascular and inflammatory diseases. His applied research and development work in this area led to novel drug candidates that have progressed into clinical trials. Over the last decade, he has developed a significant track record in the biology of hydrogen sulfide, where he has identified multiple regulatory roles of this mediator in angiogenesis, reperfusion injury and cancer.
His background (two Ph.D. degrees in physiology and pharmacology, coupled with his medical background [M.D.]) and his diverse research interests, which range from basic cell death mechanisms to vascular injury, diabetes, shock, heart failure, inflammatory diseases, diabetes and its complications) as well as his dual activities in academia (basic research) and in industry (applied research and drug development) are substantial. His expertise range from the regulation of nitric oxide synthases, through oxidant and antioxidant mechanisms including peroxynitrite, and cellular inflammatory mechanisms and pathways including neuroimmunomodulation, and the bacterial protein flagellin. His background and expertise are internationally recognized in the pathogenesis of circulatory shock, diabetes, myocardial infarction, cardiomyopathy, stroke, neuroinflammation, and diabetic complications.
He has published over 500 original research articles has been in the top 10 most cited pharmacologists in the world for the last decade. He was recently listed as one of the top 400 most infuential biomedical scientists in the word. He has been continuously funded by the National Institutes of Health since 1995, and has recieved a cumulative extramural funding of over $15 million. Currently at the Department of Anesthesiology at the University of Texas Medical Branch, Professor Szabo leads a multidisciplinary team of investigators with expertise in molecular biology, cell biology, pharmacology, physiology, pathophysiology, medicinal chemistry and translational science.
Professor Szabo has received numerous awards, including the Novartis Award of the British Pharmacological Society and the Dennis Gabor Innovation Award, and the Texas Star Award. He serves or served on the Editorial Board of numerous leading journals, including the British Journal of Pharmacology, the Journal of Pharmacology and Experimental Therapeutics, Shock, and Molecular Medicine. He is an Elected Fellow of the British Pharmacological Society and an Elected Member of the American Society for Clinical Investigation.
Especialista en Cuidado Intensivo – Medicina Interna. Unidad de Cuidado Intensivo. Fundación Valle del Lili, Cali – Colombia. (2007 – Presente)
Miembro de la Sociedad Europea de Cuidado Intensivo (ESICM). (2007 – Presente)
Jurado académico del programa ECCRN (European Critical Care Research Network), Sociedad Europea de Cuidado Intensivo (ESICM) (2009 – Presente)
Profesor del Programa de Cuidado Intensivo Universidad del Valle. Cali, Colombia (2007 – a la actualidad)
Profesor del programa postgrado en Medicina Interna y Medicina de Urgencias. Universidad CES - Medellín. Fundación Valle del Lili. Cali, Colombia (2007 – a la actualidad)
Profesor del programa postgrado en Medicina Interna, Universidad ICESI. Cali, Colombia (2010 – a la actualidad)
Profesor Cátedra de Fisiología Médica, Universidad ICESI. Cali, Colombia (2011 – a la actualidad)
Editorial Reviewer for:
Intensive Care Medicine (2009 – a la fecha)
Critical Care Medicine (2009 – a la fecha)
Critical Care (2009 – a la fecha)
BMC Anesthesiology (2010 – a la fecha)
Annals of Intensive Care (2010 - a la fecha)
Minerva Anestesiologica (Journal of the Italian National Society of Anaesthesia, Analgesia, Resucitation and Intensive care – SIAARTI). (2010 – a la fecha)
Journal of Clinical Monitoring and Computing (2.015 – a la fecha)
Journal of Critical Care (2.015 – a la fecha)
PLOS One (2.015 – a la fecha)
Revista Brasileira de Terapia Intensiva (2.015 – a la fecha)
Revisor / Jurado académico del programa ECCRN (European Critical Care Research Network), Sociedad Europea de Cuidado Intensivo (European Society of Intensive Care Medicine - ESICM)
John Marshall is a Professor of Surgery at the University of Toronto, and a trauma surgeon and intensivist at St. Michael’s Hospital in Toronto, Canada. His academic interests are sepsis, trauma, and the innate immune response. His laboratory studies the cellular mechanisms that prolong neutrophil survival in critical illness by preventing neutrophil programmed cell death, or apoptosis. Professor Marshall has an active clinical research interest in sepsis and ICU-acquired infection, and in the design of clinical trials and outcome measures. He has published more than 300 manuscripts, and 80 book chapters, and is the editor of 2 books. He is the founding chair of the International Forum of Acute Care Trialists (InFACT) – a global network of investigator-led critical care clinical research groups, Secretary-General of the World Federation of Societies of Intensive and Critical Care Medicine, and vice-chair of the International Severe Acute Respiratory and Emerging Infections Consortium. He is past-chair of the International Sepsis Forum, past-President of the Surgical Infection Society, and past-chair of the Canadian Critical Care Trials Group. He has given invited lectures at more than 450 meetings around the world, and is a member of the editorial boards of seven journals.
Massimo Girardis is an Associate Professor in Anaesthesia and Intensive care at the University of Modena and Reggio Emilia, Italy. Professor Girardis began his career at the Department of Physiology and Biology of the University of Udine, Italy, and in 1994 and 1995 he participated in the Euromir Missions of the European Space Agency in Moscow for the study of the effects of prolonged microgravity in humans. In 1997 he completed his formation as Anesthesiologist and Intensivist, and after a one-year experience at the Department of Anaesthesia, Physiology and Pharmacology of the University of Geneva, Switzerland, he became responsible for the running of the intensive care unit at the University Hospital of Udine. Prof Girardis then moved to the University of Modena, where he became chief of the surgical intensive care unit. Prof Girardis is the coordinator of the working group on infection and sepsis of the Italian Society of Anaesthesia and Resuscitation and in this Society is also member of the directive council since 2012. He is the author of over 100 publications and serves as reviewer for numerous high level scientific journals.
Dr. Adhikari received his medical degree from McGill University and then completed residency training in Internal Medicine (McGill) and Respirology and Critical Care Medicine (Manitoba and Toronto). He subsequently obtained a MSc in Heath Research Methodology from McMaster University under the supervision of Drs. Maureen Meade and Deborah Cook.
XIII Fórum Internacional de Sepse.
© All Rights Reserved. Desenvolvimento
Plano A Comunicação e Eventos